The Dynamic Change of Practical Inflammation and Immunity Markers in Cancer Patient Receiving Immune-Enhanced Nutrition during Concurrent Chemoradiotherapy

Phase 2

Completed

• Conditions: Head and neck cancerEsophageal cancerUterine cervical cancer; immunonutrition; immune enhancing nutrition; radiotherapy; NLR; Neutrophil to lymphocyte ratio; ALC; lymphocyte

• Registration Number: TCTR20200819005
• Lead Sponsor: Faculty of Medicine, Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-07-31
• Study Start: 2020-08-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

1. Nonmetastatic head and neck cancer, esophageal cancer, and cervical cancer patients
2. Age more than 18 years
3. Intended for CCRT either definitive treatment or adjuvant setting
4. Eastern Cooperative Oncology Group (ECOG) performance status 0-1

Exclusion Criteria

1. Metastatic disease
2. History of diabetes mellitus, renal disease, and liver disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eutrophil-to-lymphocyte ratio change between arm initial of CCRT, mid-CCRT, and end of CCRT CBC

Secondary Outcome Measures

Name	Time	Method
Absolute lymphocyte count change between arm initial of CCRT, mid-CCRT, and end of CCRT CBC